Intra-Graft Abciximab and Verapamil Combined with Direct Stenting is a Safe and Effective Strategy to Prevent Slow-flow and No-Reflow Phenomenon in Saphenous Vein Graft Lesions not Associated with Thrombus

Publisher： Bentham Science Publishers

E-ISSN： 2212-3962|7|2|152-159

ISSN： 1574-8901

Source： Recent Patents on Cardiovascular Drug Discovery, Vol.7, Iss.2, 2012-08, pp. : 152-159

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spontaneous slow flow in the saphenous vein graft: a relevant distinction of macrovascular endothelial dysfunction

By Ho Paul C.  

Heart and Vessels, Vol. 22, Iss. 4, 2007-07 ,pp. : 274-277

Springer Publishing Company

Access to resources Recommend Favorite

Plateletcrit: A platelet marker associated with saphenous vein graft disease

By Akpinar I.   Sayin M.R.   Gursoy Y.C.   Karabag T.   Kucuk E.   Buyukuysal M.C.   Aydin M.   Haznedaroglu I.C.  

Herz, Vol. 39, Iss. 1, 2014-02 ,pp. : 142-148

Springer Publishing Company

Access to resources Recommend Favorite

Saphenous Vein Graft Disease Is Associated with a Low Serum Erythropoietin Level

By  

Medical Principles and Practice, Vol. 24, Iss. 6, 2015-0 ,pp. : 544-547

Karger

Access to resources Recommend Favorite

Primary percutaneous coronary intervention: devices to prevent no-reflow phenomenon

By Weitsman Tatyana   Meerkin David  

Interventional Cardiology, Vol. 5, Iss. 3, 2013-06 ,pp. : 289-300

Future Medicine

Access to resources Recommend Favorite

Reversal of slow flow phenomenon during primary stenting by bail-out administration of abciximab

By Kaul Upendra   Sapra Rakesh   Singh Balbir   Sudan Dinesh   Ghose Tapan   Dixit NS   Wasir HS  

International Journal of Cardiovascular Interventions, Vol. 3, Iss. 1, 2000-03 ,pp. : 35-39

Informa Healthcare

Access to resources Recommend Favorite